使用健康行动过程方法的2型糖尿病老年人药物坚持的决定因素:一个横截面研究
Shiva Mohammadi1, Bahareh Khorami1, Maryam Seyedtabib2
1Department of Health care Management, School of Public Health, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
PloS one
|September 25, 2025
概括
在患有2型糖尿病的老年人中,药物坚持度较低. 吸烟和感知到的障碍增加了不坚持,而自我效能和应对计划改善了它.
科学领域:
- 老年学是一门学科.
- 内分泌学 在内分泌学.
- 健康心理学 心理健康心理学
背景情况:
- 药物坚持对于管理2型糖尿病等慢性疾病至关重要.
- 不遵守导致疾病进展,住院和死亡风险增加.
- 患有2型糖尿病的老年人代表了对药物不服药的脆弱人群.
研究的目的:
- 为了确定2型糖尿病老年人的药物坚持水平.
- 通过健康行动过程方法 (HAPA) 调查影响药物坚持的因素.
主要方法:
- 一项涉及179名患有2型糖尿病的老年人的描述性分析横截面研究.
- 通过莫里斯基药物坚持度表 (MMAS-8-Item) 和HAPA问卷收集的数据.
- 统计分析包括奇平方测试和多重二进制物流回归.
主要成果:
- 62%的参与者报告药物坚持程度低.
- 吸烟和感知到的障碍与增加的不坚持有显著的关联.
- 恢复自我有效性和应对计划与减少不坚持有关.
结论:
- 患有2型糖尿病的老年人表现出低于最佳的药物坚持.
- 干预措施应解决戒烟问题,感知障碍,增强自我效能和应对计划.
- 调查结果为慢性疾病管理中的行为干预政策和规划提供了信息.
相关概念视频
Drug Dosing: Geriatric Patients
227
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
227
Pharmacodynamics in Geriatric Patients: Effects of Age
188
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
188
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
197
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
197
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
228
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
228
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
232
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
232
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
237
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
237


